Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("essai clinique")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 66937

  • Page / 2678
Export

Selection :

  • and

La loi Huriet-Serusclat : ce qui a changéDEYGAS, Béatrice.MT. Médecine thérapeutique. 2005, Vol 11, Num 1, pp 11-13, issn 1264-6520, 3 p.Article

Méthodologie des essais cliniques : Pourquoi et pour qui ? Les notions essentielles à une lecture critiqueMISMETTI, Patrick; LAPORTE, Silvy.MT. Médecine thérapeutique. 2003, Vol 9, Num 3, pp 68-72, issn 1264-6520, 5 p.Article

Clinical development of anticancer agents. A National Cancer Institute perspective = Développement de l'utilisation clinique de substances anticancéreuses. Une perspective du National Cancer InstituteMARSONI, S; WITTES, R.Cancer treatment reports. 1984, Vol 68, Num 1, pp 77-85, issn 0361-5960Article

CLINICAL TRIALSOF NEW DRUGS.DOLLERY CT; WADE OL; TURNER P et al.1977; J. R. COLL. PHYSICIANS LONDON; G.B.; DA. 1977; VOL. 11; NO 3; PP. 226-233; BIBL. 1 REF.Article

L'analyse en intention de traiter et analyse per protocoleCHABAUD, Sylvie; CUCHERAT, Michel.MT. Médecine thérapeutique. 2004, Vol 10, Num 5, pp 350-355, issn 1264-6520, 6 p.Article

Anticorps monoclonaux à usage thérapeutique: spécificités du développement clinique, évaluation par les agences, suivi de la tolérance à long termePAINTAUD, Gilles; DIVINE, Marine; LECHAT, Philippe et al.Thérapie (Paris). 2012, Vol 67, Num 4, pp 319-327, issn 0040-5957, 9 p.Article

Design Issues in Randomized Phase II/III TrialsKORN, Edward L; FREIDLIN, Boris; ABRAMS, Jeffrey S et al.Journal of clinical oncology. 2012, Vol 30, Num 6, pp 667-671, issn 0732-183X, 5 p.Article

Les ellipticines et aza-ellipticines = Ellipticins and aza-ellipticinsGISSELBRECHT, C; MARTY, M; MIGNOT, L et al.Actualités hématologiques. 1984, Vol 18, pp 193-207, issn 0567-8757Article

Designing phase III or IV trials for vaccines : Choosing between individual or cluster randomised trial designsVAUCHER, Paul.Vaccine. 2009, Vol 27, Num 13, pp 1928-1931, issn 0264-410X, 4 p.Article

MANAGEMENT OF TRIALS IN THE DEVELOPMENT OF CANCER CHEMOTHERAPY.WILLIAMS CJ; CARTER SK.1978; BRIT. J. CANCER; GBR; DA. 1978; VOL. 37; NO 3; PP. 434-447; BIBL. 24 REF.Article

THE CANCER THERAPY EVALUATION PROGRAM OF THE NATIONAL CANCER INSTITUTEMUGGIA FM; CARTER SK; MACDONALD JS et al.1981; SEMIN. ONCOL.; ISSN 0093-7754; USA; DA. 1981; VOL. 8; NO 4; PP. 394-402; BIBL. 49 REF.Article

CLINICAL TRIALS IN CANCER CHEMOTHERAPY.CARTER SK.1977; CANCER; U.S.A.; DA. 1977; VOL. 40; NO 1, SUPPL.; PP. 544-557; BIBL. 1 P. 1/2Article

Characterization and multiparameter analysis of visual adverse events in Irofulven single-agent Phase I and II trialsRAYMOND, Eric; KAHATT, Carmen; CULLEN, Michael et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7566-7574, issn 1078-0432, 9 p.Article

Guidelines for clinical evaluation of antiepileptic drugsEpilepsia (Copenhagen). 1989, Vol 30, Num 4, pp 400-408, issn 0013-9580Article

Méthodologie des essais cliniques en cancérologie : médicaments anticancéreux (2e partie) = Design of clinical trials in oncologyTRANCHAND, Brigitte; CHABAUD, Sylvie; COLOMBAN, Olivier et al.La Lettre du pharmacologue (Boulogne). 2008, Vol 22, Num 3, pp 98-110, issn 0984-452X, 13 p.Article

Journées de pharmacogie cliniqueThérapie (Paris). 1992, Vol 47, Num 5, pp 455-465, issn 0040-5957Conference Proceedings

PREDICTORS OF RESPONSE AND THEIR CLINICAL EVALUATIONCARTER SK.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 7; NO 1; PP. 1-4Article

Les essais cliniques = Clinical trialsZIVIN, J.Pour la science. 2000, Num 272, pp 100-105, issn 0153-4092Article

CLINICAL CHEMOTHERAPY: ITS CORRELATION WITH EXPERIMENTAL MODELSCARTER SK.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 74; PP. 31-36; BIBL. 5 REF.Article

Klinische Erfahrungen mit dem kurzwirksamen Opioid Alfentanil (Rapifen®) = Essais cliniques de l'opioide à action courte alfentanil (rapifen*) = Clinical experiences with the short acting opioid alfentanil (rapifen*)JOST, U; HIRSCHAUER, M; SCHMID, A et al.Anästhesie, Intensivtherapie, Notfallmedizin. 1984, Vol 19, Num 1, pp 8-13, issn 0174-1837Article

Étude des termes relevant des champs sémantiques de l'essai et de l'erreur en anglais médical = Study of words within semantic fields of the trial and the error in medical EnglishMANIEZ, François.A. sp. Anglais de spécialité. 2009, Num 56, pp 89-104, issn 1246-8185, 16 p.Article

La difficile mesure de l'effet placebo = The difficulty of measurement of placebo effectBOUSSAGEON, Rémy; GUEYFFIER, François; MOREAU, Alain et al.Thérapie (Paris). 2006, Vol 61, Num 3, pp 185-190, issn 0040-5957, 6 p.Article

Efficacité et tolérance d'un gel de carbomère fluide versus un gel de carbomère classique lors du traitement du syndrome sec = Efficacy and safety of a fluid carbomer gel versus a conventional carbomer gel in dry eye treatmentCHIAMBARETTA, F; POULIQUEN, P; MENERATH, J.-M et al.Journal français d'ophtalmologie. 2004, Vol 27, Num 2, pp 130-135, issn 0181-5512, 6 p.Article

PHASE I CLINICAL TRIAL OF A 3-DAY DIVIDED DOSE SCHEDULE OF IFOSFAMIDE (NSC 109724)NELSON RL; CREAVEN PJ; COHEN MH et al.1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 3; PP. 195-198; BIBL. 9 REF.Article

A PHASE I STUDY OF 5-AZACYTIDINE (NSC-102816)SCHNIDER BI; MAHMOODULLAH BAIG; COLSKY J et al.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 4; PP. 205-212; BIBL. 10 REF.Article

  • Page / 2678